Read More Pharma Industry News Roche reports setback in lung cancer study with tiragolumab and tecentriq combination Roche (SIX: RO, ROG; OTCQX: RHHBY) has announced disappointing results from the phase II/III SKYSCRAPER-06 study, aimed at… byPallavi MadhirajuJuly 7, 2024